Susquehanna International Group’s Zomedica Corp. ZOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,092,385
Closed -$131K 13823
2024
Q4
$131K Buy
1,092,385
+815,175
+294% +$103K ﹤0.01% 11121
2024
Q3
$38K Buy
277,210
+91,557
+49% +$12.8K ﹤0.01% 11477
2024
Q2
$27.1K Buy
+185,653
New +$27.8K ﹤0.01% 11587
2024
Q1
Sell
-357,714
Closed -$71.6K 13877
2023
Q4
$71.6K Buy
357,714
+312,969
+699% +$55K ﹤0.01% 11537
2023
Q3
$7.48K Buy
+44,745
New +$8.69K ﹤0.01% 11750
2022
Q4
Sell
-220,286
Closed -$46K 14685
2022
Q3
$46K Buy
+220,286
New +$58.3K ﹤0.01% 12262
2022
Q2
Sell
-43,257
Closed -$15K 14621
2022
Q1
$15K Sell
43,257
-21,901
-34% -$7.17K ﹤0.01% 12698
2021
Q4
$20K Sell
65,158
-50,187
-44% -$22.6K ﹤0.01% 12834
2021
Q3
$60K Buy
+115,345
New +$68.1K ﹤0.01% 12291
2021
Q2
Sell
-2,170,555
Closed -$3.43M 13748
2021
Q1
$3.43M Buy
+2,170,555
New +$3.55M ﹤0.01% 4668
2020
Q4
Sell
-45,585
Closed -$5K 12133
2020
Q3
$5K Sell
45,585
-139,583
-75% -$19.2K ﹤0.01% 10447
2020
Q2
$44K Buy
+185,168
New +$35.3K ﹤0.01% 9788

Other funds holding ZOM

Susquehanna International Group's ZOM Position: Q1 2025 in Review

Susquehanna International Group sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 1,092,385 shares — an estimated $131K sold.

Susquehanna International Group first reported a position in ZOM in Q2 2020 and held it in 12 quarters. The position peaked at $3.43M in Q1 2021. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • Susquehanna International Group reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • Susquehanna International Group sold 1,092,385 Zomedica Corp. shares in Q1 2025, an estimated $131K.
  • Susquehanna International Group first reported a position in Zomedica Corp. in Q2 2020 and held it in 12 quarters.
  • Susquehanna International Group's Zomedica Corp. position peaked at $3.43M in Q1 2021.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.